MedPath

Introduction of a new therapy to treat Avoidant Restrictive Food Intake Disorder (ARFID) for adults at the Sunshine Coast Eating Disorder Service

Not Applicable
Conditions
Avoidant Restrictive Food Intake Disorder
Mental Health - Eating disorders
Registration Number
ACTRN12622000860763
Lead Sponsor
Copeland Winten
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

Adult, living in the Sunshine Coast Hospital and Health Service region, diagnosis of ARFID, able to comprehend cognitive behavioural therapy,

Exclusion Criteria

Other primary eating disorder diagnosis.
Currently accessing other interventions for ARFID
Unable to comprehend CBT-AR, ie due to intellectual disability.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of Avoidant Restrictive Food Intake Disorder (ARFID). As per the PRADI-AR-Q (self report measure of ARFID symptomology) and psychiatric assessment. [After completion of CBT-AR. ]
Secondary Outcome Measures
NameTimeMethod
Weight % Change assessed by digital scales and BMI (kg/m2) measured through stadiometer and digital scales. As a composite outcome. [Pre(week 0) and Post Therapy(week 20-30). ];Food Neophobia Scale (FNS). [Pre (week 0) and Post (week 20-30) therapy];Clinical Impairment Scale (CIA). [Pre (week 0) and post (week 20-30) CBT-AR therapy. ];Depression Anxiety Stress Scale-21 (DASS-21) [Pre (week 0) and post (week 20-30) of CBT-AR therapy.];Normal Eating Scale (NES) [Pre (week 0) and post (week 20-30) CBT-AR therapy. ];Nutrition Blood Panel[Pre (week 0) and post (week 20-30) CBT-AR therapy. ];Food Recall (dietary recall collected by dietitian) [Pre (week 0) and post (week 20-30) CBT-AR therapy. ];Client Satisfaction Questionnaire (CSQ-8) [Post CBT-AR therapy];Eating Disorder Examination Questionnaire (EDE-Q)[Pre (week 0) CBT-AR therapy];Australian Core Food Score [Pre (week 0) and post (week 20-30) CBT-AR therapy. ]
© Copyright 2025. All Rights Reserved by MedPath